Research
Metabolic adaptation
PGDP levels at the 3-month visit were positively correlated with improvements in fat mass, glycaemia, lipaemia, and liver function.
Monitoring PGDP levels may provide insights into metabolic improvements in patients undergoing treatment.
StrongSupportsmedium confidence
PGDP levels at the 3-month visit were positively and independently correlated with improvements in fat mass, glycaemia, lipaemia and liver function.
Why this rating
Based on the interventional study design with clear correlations reported.
Source
Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study
Konstantinos Stefanakis et al. · Diabetes Obesity and Metabolism · 2023
rct · n=17Cited 15×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →